Athersys Expands Bristol-Myers Squibb Deal

Aug 05, 2002

NEW YORK, Aug. 5-Athersys said today that it is expanding its partnership with Bristol-Myers Squibb to provide additional validated drug targets for the next three years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

In Brief This Week: Agilent, Edico Genome, Alere, and More
White Guinea Yam Genome Sequence Offers Insight Into Dioecy Plants
Signature Science Wins $2.9M IARPA Contract for Biological Threat Detection Computational Tools
People in the News: Olivier Elemento, Andrew Witty, Michael Korn, More
Verge Genomics Forms ALS Research Collaboration
UK Foundation Outlines Recommendations for Effective ctDNA Testing in Lung Cancer

The Scan

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Main menu